Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-20

Clinical Trial Update: Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO [NA]

View source ↗

Summary

An update on a clinical trial assessing the combination of budesonide, formoterol, and tiotropium for acute exacerbations in asthma-COPD overlap.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • Formoterol (formoterol)
  • tiotropium (tiotropium)

Snippet

Sponsor: Huashan Hospital | Conditions: Asthma-COPD Overlap | NA | Status: UNKNOWN